Although statistical significance diminished upon inclusion of the Harvard Lung Cancer Study cohort (p = 3.52 × 10−3), the findings suggested a possible role for CYP4F3 in lung cancer predisposition, particularly among smokers, warranting further functional investigation [78]. The gene discussed is CYP4F3; the disease is lung carcinoma.